These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia. Votava F, Török D, Kovács J, Möslinger D, Baumgartner-Parzer SM, Sólyom J, Pribilincová Z, Battelino T, Lebl J, Frisch H, Waldhauser F, Middle European Society for Paediatric Endocrinology -- Congenital Adrenal Hyperplasia (MESPE-CAH) Study Group. Eur J Endocrinol; 2005 Jun; 152(6):869-74. PubMed ID: 15941926 [Abstract] [Full Text] [Related]
27. [Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 3. An enzyme-linked immunosorbent assay for dried blood 17 alpha-hydroxyprogesterone]. Fukushi M, Arai O, Mizushima Y, Takasugi N, Fujieda K, Matsuura N. Nihon Naibunpi Gakkai Zasshi; 1987 Feb 20; 63(2):113-22. PubMed ID: 3494638 [Abstract] [Full Text] [Related]
28. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values. Fingerhut R. Steroids; 2009 Aug 20; 74(8):662-5. PubMed ID: 19463687 [Abstract] [Full Text] [Related]
29. Blood-spot 17 alpha-hydroxyprogesterone radioimmunoassay in the follow-up of congenital adrenal hyperplasia. Sólyom J. Clin Endocrinol (Oxf); 1981 Jun 20; 14(6):547-53. PubMed ID: 7296904 [Abstract] [Full Text] [Related]
30. "Dot-17 alpha-hydroxyprogesterone" radioimmunoassay for identification of congenital adrenal hyperplasia in young infants. Sólyom J, Hervei S, Marossy P, Sólyom E, Babosa M, Szombathy G. Acta Paediatr Scand; 1981 Nov 20; 70(6):913-7. PubMed ID: 7324946 [Abstract] [Full Text] [Related]
31. [Neonatal mass-screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. II. A pilot neonatal mass-screening study in the west of Shizuoka Prefecture, Japan]. Shimozawa K. Nihon Naibunpi Gakkai Zasshi; 1983 Dec 20; 59(12):1860-73. PubMed ID: 6609092 [Abstract] [Full Text] [Related]
32. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia. Cavarzere P, Samara-Boustani D, Flechtner I, Dechaux M, Elie C, Tardy V, Morel Y, Polak M. Eur J Endocrinol; 2009 Aug 20; 161(2):285-92. PubMed ID: 19451212 [Abstract] [Full Text] [Related]
33. Blood-spot 17-hydroxyprogesterone daily profiles in infants with congenital adrenal hyperplasia. Sólyom J, Hosszu E, Gács G. Exp Clin Endocrinol; 1990 Sep 20; 96(1):52-6. PubMed ID: 2279525 [Abstract] [Full Text] [Related]
34. Serum 17 alpha-hydroxyprogesterone in infants and children as measured by a direct radioimmunoassay kit. Lee A, Ellis G. Clin Biochem; 1991 Dec 20; 24(6):505-11. PubMed ID: 1773491 [Abstract] [Full Text] [Related]
35. Neonatal screening for congenital adrenal hyperplasia. Cacciari E, Balsamo A, Cassio A, Piazzi S, Bernardi F, Salardi S, Cicognani A, Pirazzoli P, Zappulla F, Capelli M. Arch Dis Child; 1983 Oct 20; 58(10):803-6. PubMed ID: 6639129 [Abstract] [Full Text] [Related]
36. [Screening for congenital adrenal hyperplasia in Hungary]. Sólyom J. Orv Hetil; 1989 Sep 10; 130(37):1979-82, 1985-6. PubMed ID: 2780047 [Abstract] [Full Text] [Related]
38. Twenty years experience in rapid identification of congenital adrenal hyperplasia in Hungary. Török D, Eckhardt G, Sólyom J. Eur J Pediatr; 2003 Dec 10; 162(12):844-9. PubMed ID: 14648216 [Abstract] [Full Text] [Related]
40. A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing. Gong LF, Gao X, Yang N, Zhao JQ, Yang HH, Kong YY. J Pediatr Endocrinol Metab; 2019 Mar 26; 32(3):253-258. PubMed ID: 30817302 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]